Hidradenitis Suppurativa and Bipolar Disorders: A Role for Lithium Therapy?
Open Access
- 1 July 2020
- journal article
- letter
- Published by S. Karger AG in Dermatology
- Vol. 236 (4), 305-306
- https://doi.org/10.1159/000505912
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Hidradenitis Suppurativa and Bipolar Disorders: A Population-Based StudyDermatology, 2020
- Development and validation of the International Hidradenitis Suppurativa Severity Score System ( IHS 4), a novel dynamic scoring system to assess HS severityBritish Journal of Dermatology, 2017
- Hurley Staging Refined: A Proposal by the Dutch Hidradenitis Suppurativa Expert GroupActa Dermato-Venereologica, 2017
- Lithium and skin: dermatologic manifestations of lithium therapyInternational Journal of Dermatology, 2008
- How lithium treatment generates neutrophilia by enhancing phosphorylation of GSK-3, increasing HIF-1 levels and how this path is important during engraftmentBone Marrow Transplantation, 2007
- Expression of G-proteins and regulators of G-protein signalling in neutrophils of patients with bipolar disorder: effects of mood stabilizersBipolar Disorders, 2002
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithiumJournal of the American Academy of Dermatology, 1995